Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11709567 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
Condition: Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Radiation: standard subtotal nodal irradiation

Indicates status has not been verified in more than two years